ImmunoCellular amends follow-on

ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Calabasas, Calif.
Business: Cancer
Date

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE